outbreak
atyp
pneumonia
guangdong
provinc
peopl
republ
china
continu
sinc
novemb
report
affect
peopl
caus
death
adjac
hong
kong
surveil
sever
atyp
pneumonia
heighten
public
hospit
network
hospit
author
hong
kong
end
februari
cluster
patient
pneumonia
note
hong
kong
along
affect
close
contact
healthcar
worker
diseas
respond
empir
antimicrobi
treatment
acut
communityacquir
typic
atyp
pneumonia
bacteriolog
virolog
pathogen
known
caus
pneumonia
identifi
thu
new
disord
call
sever
acut
respiratori
syndrom
sar
subsequ
sar
spread
worldwid
involv
patient
north
america
europ
asian
countri
investig
patient
hong
kong
tri
identifi
causal
agent
includ
studi
patient
fit
modifi
definit
sar
admit
three
acut
region
hospit
hong
kong
feb
march
briefli
case
definit
fever
cough
short
breath
new
pulmonari
infiltr
chest
radiographi
histori
exposur
patient
sar
absenc
respons
empir
antimicrobi
coverag
typic
atyp
pneumonia
lactam
macrolid
fluoroquinolon
tetracyclin
collect
nasopharyng
aspir
serum
sampl
patient
pair
acut
convalesc
sera
faec
avail
patient
lungbiopsi
tissu
sampl
one
patient
process
viral
cultur
reversetranscriptas
pcr
rtpcr
routin
histopatholog
examin
electron
microscopi
use
control
nasopharyng
aspir
faec
sera
submit
microbiolog
investig
diseas
patient
whose
ident
mask
sar
patient
medic
record
review
retrospect
attend
physician
clinic
microbiologist
routin
haematolog
biochem
microbiolog
workup
done
includ
bacteri
cultur
blood
sputum
serolog
nasopharyng
aspir
virolog
nasopharyng
aspir
assess
rapid
immunoflouresc
antigen
detect
influenza
b
parainfluenza
type
respiratori
syncyti
viru
adenoviru
cultur
genet
sequenc
coronaviru
two
patient
develop
rtpcr
detect
coronaviru
sequenc
nasopharyng
aspir
sampl
total
rna
clinic
sampl
revers
transcrib
random
hexam
cdna
amplifi
primer
presenc
mmoll
magnesium
chlorid
min
follow
cycl
min
min
min
coronavirusinfect
fetal
rhesu
kidney
cell
fix
aceton
use
indirect
immunofluoresc
assay
detect
serolog
respons
viru
find
genet
sequenc
inform
unknown
rna
viru
random
rtpcr
assay
total
rna
virusinfect
virusuninfect
fetal
rhesu
kidney
cell
isol
rna
sampl
revers
transcrib
primer
na
c
g
cdna
amplifi
primer
uniqu
pcr
product
size
infect
cell
prepar
clone
sequenc
genet
homolog
compar
genbank
routin
receipt
inocul
sampl
done
biosafeti
laboratori
laboratori
procedur
involv
cultur
viru
done
biosafeti
contain
compar
risk
factor
associ
complic
uncompl
diseas
test
categor
variabl
continu
variabl
test
student
test
p
valu
less
taken
signific
use
spss
version
analys
multivari
analysi
sinc
number
case
small
meaning
result
obtain
sponsor
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
patient
sar
ethnic
chines
repres
five
differ
epidemiolog
link
cluster
sporad
case
fit
case
definit
admit
hospit
mean
day
sd
onset
symptom
median
age
year
rang
femaletomal
ratio
among
patient
healthcar
worker
five
histori
visit
hospit
major
outbreak
sar
household
contact
social
contact
patient
sar
four
recent
travel
mainland
china
present
complaint
patient
feverish
short
breath
cough
myalgia
present
half
patient
anorexia
also
report
initi
examin
auscultatori
find
crepit
decreas
air
entri
present
patient
dri
cough
report
patient
radiolog
evid
consolid
time
admiss
involv
one
zone
two
zone
three
zone
one
despit
high
fever
patient
evid
leucocytosi
peripher
blood
test
lymphopenia
present
leucopenia
thrombocytopenia
anaemia
tabl
alanin
aminotransferas
ul
creatinin
kinas
ul
rais
respect
routin
microbiolog
investig
known
virus
bacteria
cultur
antigen
detect
pcr
neg
case
blood
cultur
posit
escherichia
coli
one
man
age
year
admit
intens
care
find
attribut
hospitalacquir
urinarytract
infect
klebsiella
pneumonia
haemophilu
influenza
isol
sputum
sampl
two
patient
admiss
oral
levofloxacin
mg
everi
h
given
nine
patient
amoxicillinclavulan
given
intraven
g
h
interv
oral
mg
three
time
daili
intraven
oral
clarithromycin
mg
everi
h
given
anoth
patient
four
patient
receiv
oral
oseltamivir
mg
twice
daili
one
patient
intraven
ceftriaxon
g
everi
h
oral
azithromycin
mg
everi
h
oral
amantadin
mg
twice
daili
given
empir
coverag
typic
atyp
pneumonia
time
write
patient
progress
sever
diseas
oxygen
desatur
requir
intens
care
ventilatori
support
mean
day
mean
time
onset
symptom
worsen
day
intraven
ribavirin
mgkg
everi
h
day
steroid
intraven
hydrocortison
mg
everi
h
hydrocortison
mg
everi
h
methylprednisolon
mgkg
everi
h
two
three
dose
tail
week
given
patient
mean
day
onset
symptom
six
patient
given
ribavirin
steroid
intub
ventil
intens
care
two
consist
respons
term
resolut
fever
decreas
respiratori
support
later
radiolog
resolut
wherea
four
fluctuat
fever
static
requir
respiratori
support
risk
factor
associ
sever
complic
diseas
requir
intens
care
ventilatori
support
older
age
sever
lymphopenia
impair
alanin
aminotransferas
delay
start
ribavirin
steroid
tabl
complic
case
treat
ribavirin
steroid
admiss
intensivecar
unit
wherea
uncompl
case
start
ribavirin
steroid
gener
ward
expect
uncompl
case
recov
improv
wherea
eight
patient
complic
wbcwhiteblood
cell
two
patient
diabet
mellitu
one
hypertroph
obstruct
cardiomyopathi
one
chronic
activ
hepat
b
one
brain
tumour
patient
essenti
hypertens
requir
intensivecar
support
defin
resolut
fever
within
h
decreas
ventilatori
support
radiolog
improv
tabl
risk
factor
associ
sever
diseas
requir
intens
care
ventilatori
support
diseas
worsen
one
death
time
write
patient
monitor
mean
day
sd
time
write
two
viru
isol
identifi
coronaviru
isol
two
patient
one
open
lung
biopsi
sampl
male
hong
kong
chines
resid
age
year
nasopharyng
aspir
woman
age
year
good
previou
health
man
histori
h
social
contact
chines
visitor
come
guangzhou
mainland
china
later
die
sar
day
exposur
patient
present
fever
malais
myalgia
headach
crepit
present
right
lower
zone
correspond
alevolar
shadow
chest
radiograph
haematolog
investig
reveal
lymphopenia
l
normal
total
whitecel
platelet
count
alanin
aminotransferas
ul
creatinin
phosphokinas
ul
impair
despit
combin
oral
azithromycin
amantadin
intraven
ceftriaxon
increas
bilater
pulmonari
infiltr
progress
oxygen
desatur
therefor
open
lung
biopsi
done
day
admiss
histopatholog
examin
show
mild
interstiti
inflamm
scatter
alveolar
pneumocyt
show
cytomegali
granular
amphophil
cytoplasm
enlarg
nuclei
promin
nucleoli
cell
show
inclus
typic
herp
viru
adenoviru
infect
requir
ventil
intens
care
surgic
procedur
empir
intraven
ribavirin
hydrocortison
given
die
day
admiss
coronaviru
rna
detect
nasopharyng
aspir
lung
biopsi
sampl
postmortem
lung
sampl
signific
rise
antibodi
titr
coronaviru
isol
femal
patient
coronaviru
isol
histori
good
health
recent
travel
guangzhou
day
present
fever
diarrhoea
day
return
hong
kong
physic
examin
show
crepit
right
lower
zone
correspond
alveolar
shadow
chest
radiograph
investig
reveal
leucopenia
l
lymphopenia
l
thrombocytopenia
l
despit
empir
antimicrobi
coverag
amoxicillinclavulan
clarithromycin
oseltamivir
worsen
day
admiss
requir
mechan
ventil
intens
care
day
gradual
improv
without
treatment
ribavirin
steroid
nasopharyng
aspir
posit
rtpcr
coronaviru
seroconvert
titr
less
one
per
one
per
coronaviru
isol
virus
isol
fetal
rhesu
kidney
cell
lung
biopsi
nasopharyng
aspir
respect
two
patient
initi
cytopath
effect
note
appear
round
refractil
cell
appear
day
inocul
cytopath
effect
progress
initi
cultur
tube
subsequ
passag
appear
h
two
viru
isol
react
routin
panel
reagent
use
identifi
viru
isol
includ
influenza
b
parainfluenza
type
adenoviru
respiratori
syncyti
viru
dako
glostrup
denmark
also
react
rtpcr
assay
influenza
human
metapneumoviru
pcr
assay
mycoplasma
viru
ether
sensit
show
envelop
viru
electron
microscopi
neg
stain
potassium
phosphotungst
ph
ultracentrifug
cellcultur
extract
show
presenc
pleomorph
envelop
viru
particl
around
nm
rang
nm
diamet
surfac
morpholog
compat
coronaviru
figur
thinsect
electron
microscopi
infect
cell
reveal
viru
particl
nm
diamet
within
smooth
wall
vesicl
cytoplasm
figur
b
viru
particl
also
seen
cell
surfac
overal
find
compat
coronaviru
infect
cell
thinsect
electron
micrograph
lung
biopsi
sampl
male
contain
nm
viral
particl
cytoplasm
desquam
cell
viral
particl
similar
size
morpholog
observ
cell
cultur
viru
isol
patient
figur
rtpcr
product
gener
random
primer
rtpcr
assay
analys
uniqu
band
found
virusinfect
sampl
clone
sequenc
clone
examin
one
contain
bp
unknown
origin
identifi
sequenc
analysi
dna
fragment
suggest
sequenc
weak
homolog
virus
famili
coronavirida
deduct
aminoacid
sequenc
aminoacid
unknown
sequenc
howev
highest
homolog
rna
polymeras
bovin
coronaviru
murin
hepat
viru
confirm
viru
belong
famili
coronavirida
phylogenet
analysi
protein
sequenc
show
viru
although
close
relat
group
ii
coronavirus
distinct
viru
figur
base
bp
sequenc
isol
specif
primer
detect
new
viru
design
rtpcr
detect
human
pneumoniaassoci
recent
serum
sampl
patient
sar
evid
antibodi
coronaviru
patient
pair
acut
convalesc
sera
avail
seroconvert
fourfold
increas
antibodi
titr
viru
five
pair
sera
addit
sar
patient
cluster
outsid
studi
group
also
test
provid
wider
sampl
sar
patient
commun
seroconvert
none
sera
patient
respiratori
diseas
none
blood
donor
detect
antibodi
seroposit
human
pneumoniaassoci
coronaviru
one
serum
sampl
viral
rna
detect
nasopharyng
aspir
stool
deem
evid
infect
coronaviru
patient
evid
infect
five
patient
virolog
evid
coronaviru
infect
one
serum
sampl
test
day
onset
clinic
diseas
outbreak
sar
unusu
sever
way
especi
appear
cluster
patient
pneumonia
healthcar
worker
famili
contact
seri
patient
investig
convent
pathogen
atyp
pneumonia
prove
neg
howev
viru
belong
famili
coronavirida
isol
lung
biopsi
nasopharyng
aspir
two
sar
patient
patient
sar
serolog
respons
viru
famili
coronavirida
includ
genu
coronaviru
toroviru
envelop
rna
virus
caus
diseas
human
be
anim
previous
known
human
coronavirus
type
major
caus
common
cold
occasion
caus
pneumonia
older
adult
neonat
immunocompromis
patient
coronavirus
report
import
caus
pneumonia
militari
recruit
account
case
studi
human
coronavirus
infect
neuron
viral
rna
detect
brain
patient
multipl
sclerosi
hand
sever
anim
coronavirus
eg
porcin
transmiss
gastroenter
viru
murin
hepat
viru
avian
infecti
bronchit
viru
caus
respiratori
gastrointestin
neurolog
hepat
diseas
respect
host
phylogenet
human
pneumoniaassoci
coronaviru
close
relat
known
human
anim
coronaviru
toroviru
base
analysi
bp
fragment
polymeras
gene
show
viru
belong
antigen
group
coronavirus
along
murin
hepat
viru
bovin
coronaviru
howev
virus
coronavirida
undergo
heterolog
recombin
within
viru
famili
genet
analysi
part
genom
need
done
natur
new
viru
conclus
defin
biolog
genet
clinic
data
taken
togeth
show
new
viru
one
two
known
human
coronavirus
antibodi
previous
recognis
human
coronavirus
widespread
human
popul
lack
serolog
reactiv
novel
pneumoniaassoci
coronaviru
among
patient
impli
littl
antigen
cross
reactiv
virus
patient
clinic
defin
sar
either
serolog
rtpcr
evid
infect
viru
contrast
neither
antibodi
viral
rna
detect
healthi
control
patient
acut
convalesc
sera
avail
rise
antibodi
titr
human
pneumoniaassoci
coronaviru
strengthen
content
recent
infect
viru
necessari
factor
evolut
sar
addit
five
pair
acut
convalesc
sera
test
patient
hospit
hong
kong
also
show
seroconvers
viru
five
patient
sar
serolog
virolog
evid
coronaviru
infect
need
later
convalesc
sera
test
defin
whether
seroconvert
subsequ
howev
concord
human
pneumoniaassoci
coronaviru
clinic
definit
sar
seem
remark
given
clinic
case
definit
never
perfect
evid
humanmetapneumoviru
infect
rtpcr
rise
antibodi
titr
detect
patient
pathogen
consist
detect
therefor
highli
like
coronaviru
either
caus
sar
necessari
prerequisit
diseas
progress
whether
microbi
nonmicrobi
cofactor
play
part
progress
diseas
remain
investig
describ
clinic
present
complic
sar
less
patient
coronavir
pneumonia
upperrespiratorytract
symptom
expect
atyp
pneumonia
respiratori
symptom
posit
auscultatori
find
disproport
mild
compar
chest
radiograph
find
gastrointestin
symptom
present
patient
symptom
relev
sinc
viral
rna
detect
faec
patient
coronavirus
associ
diarrhoea
anim
human
be
high
incid
alter
liver
function
leucopenia
sever
lymphopenia
thrombocytopenia
subsequ
evolut
adult
respiratori
distress
syndrom
suggest
sever
system
inflammatori
damag
induc
human
pneumoniaassoci
coronaviru
thu
immunomodul
steroid
treatment
may
import
complement
empir
antivir
treatment
ribavirin
pertin
sever
human
diseas
associ
avian
influenza
subtyp
anoth
viru
cross
anim
human
be
also
postul
immunopatholog
compon
common
diseas
patient
sever
sar
adult
lymphopenia
variabl
organ
dysfunct
beyond
respiratori
tract
window
opportun
around
day
exist
onset
symptom
respiratori
failur
sever
complic
case
strongli
associ
underli
diseas
delay
use
ribavirin
steroid
treatment
clinic
experi
first
case
start
combin
treatment
earli
subsequ
case
gener
uncompl
time
admiss
overal
mortal
time
write
use
treatment
regimen
eight
complic
case
still
shown
notabl
respons
detail
analysi
therapeut
respons
combin
regimen
imposs
given
heterogen
dose
time
start
treatment
choic
ribavirin
made
empir
ground
caus
identifi
might
review
invitro
suscept
human
pneumoniaassoci
coronaviru
antivir
better
understood
anoth
factor
associ
sever
diseas
acquisit
diseas
household
contact
peopl
infect
way
may
higher
dose
durat
viral
exposur
presenc
underli
diseas
peopl
expos
exampl
social
contact
clinic
descript
pertain
larg
sever
case
admit
hospit
present
data
full
clinic
spectrum
emerg
coronaviru
infect
commun
among
outpati
avail
diagnost
test
describ
help
address
question
addit
allow
question
address
period
viru
shed
communic
convalesc
presenc
viru
bodi
fluid
excreta
presenc
viru
shed
incub
period
epidemiolog
data
present
seem
suggest
viru
spread
droplet
direct
indirect
contact
although
airborn
spread
rule
find
infecti
viru
respiratori
tract
support
content
preliminari
evid
also
suggest
viru
may
shed
faec
howev
detect
viral
rna
prove
viru
viabl
transmiss
viabl
viru
detect
faec
potenti
addit
rout
transmiss
sever
anim
coronavirus
spread
via
faecalor
rout
sampl
patient
sar
readili
distinguish
sampl
patient
receipt
laboratori
thu
initi
process
sampl
done
biohazard
contain
howev
cultur
viru
done
biosafeti
contain
contain
measur
prove
success
far
laboratori
infect
document
provid
evid
viru
coronaviru
famili
causal
agent
sar
howev
remain
possibl
virus
act
opportunist
secondari
invad
increas
diseas
progress
hypothesi
need
investig
contributor
j
peiri
k
yuen
coprincip
investig
jointli
wrote
report
supervis
virolog
clinic
compon
studi
l
l
poon
obtain
viral
sequenc
data
develop
rtpcr
assay
guan
k
h
chan
w
lim
j
nichol
phylogenet
analysi
clinic
virolog
electron
microscopi
identifi
novel
viru
k
ng
n
c
tsang
r
yung
w
lim
coordin
microbiolog
investig
analys
overal
result
research
involv
collect
analysi
clinic
data
woman
found
elev
alkalin
phosphatas
alp
concentr
iul
normal
iul
year
ago
routin
laboratori
evalu
outsid
hospit
patient
symptom
workup
done
year
later
undergo
followup
magnet
reson
imag
mri
scan
previou
stroke
multipl
mix
blastic
lytic
lesion
seen
skull
suggest
paget
diseas
figur
skull
enlarg
slightli
compress
frontal
lobe
bilater
patient
remain
well
includ
normal
hear
neurolog
deficit
prior
stroke
serum
alp
iul
liver
function
test
normal
comput
tomographi
scan
ct
confirm
paget
natur
lesion
bone
scan
show
intens
isotop
uptak
skull
area
uptak
consid
due
degen
joint
diseas
patient
start
oral
bisphosphon
paget
diseas
commonli
seen
elderli
popul
elev
alp
concentr
routin
laboratori
evalu
common
present
mani
patient
alp
mildli
elev
howev
concentr
high
skull
involv
suspect
treatment
bisphosphon
mandatori
prevent
neurolog
complic
